Combating Intracellular Pathogens with Repurposed Host-Targeted Drugs.

about

Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment.

P2860

Q54110307-44A7209E-EECF-486F-ADC0-E5F6D96B53F6

P2860

Combating Intracellular Pathogens with Repurposed Host-Targeted Drugs.

Item

http://www.wikidata.org/entity/Q47235181

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Combating Intracellular Pathogens with Repurposed Host-Targeted Drugs.

@en

Combating Intracellular Pathogens with Repurposed Host-Targeted Drugs.

@nl

type

Item

label

Combating Intracellular Pathogens with Repurposed Host-Targeted Drugs.

@en

Combating Intracellular Pathogens with Repurposed Host-Targeted Drugs.

@nl

altLabel

Combating Intracellular Pathogens with Repurposed Host-Targeted Drugs

@en

prefLabel

Combating Intracellular Pathogens with Repurposed Host-Targeted Drugs.

@en

Combating Intracellular Pathogens with Repurposed Host-Targeted Drugs.

@nl

P1476

Combating Intracellular Pathogens with Repurposed Host-Targeted Drugs.

@en

P2093

Shirit Einav

http://www.w3.org/2001/XMLSchema#string

Stanford Schor

http://www.w3.org/2001/XMLSchema#string

P2860

Curing a viral infection by targeting the host: the example of cyclophilin inhibitors

Targeting cancer with kinase inhibitors

Nitazoxanide: a first-in-class broad-spectrum antiviral agent

Cyclosporine Inhibits Flavivirus Replication through Blocking the Interaction between Host Cyclophilins and Viral NS5 Protein

Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomes

Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions

A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults

Identification of host-targeted small molecules that restrict intracellular Mycobacterium tuberculosis growth

Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection.

Repositioning: the fast track to new anti-malarial medicines?

P304

88-92

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACSINFECDIS.7B00268

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29298032

http://www.w3.org/2001/XMLSchema#string

P932

5807128

http://www.w3.org/2001/XMLSchema#string

Combating Intracellular Pathogens with Repurposed Host-Targeted Drugs.

about

P2860

P2860

Combating Intracellular Pathogens with Repurposed Host-Targeted Drugs.

description

name

type

label

altLabel

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932